Discoveries from ARVO
Discoveries from ARVO
Source/Disclosures
Source:

Healio Interview

Disclosures: Curcio reports receiving research support from Genentech and Heidelberg Engineering, and is a stockholder with Macregen Inc.
July 29, 2020
1 min watch
Save

VIDEO: When treating AMD, ‘believe the B scans’

Source/Disclosures
Source:

Healio Interview

Disclosures: Curcio reports receiving research support from Genentech and Heidelberg Engineering, and is a stockholder with Macregen Inc.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this exclusive video, Christine A. Curcio, PhD, White-McKee endowed professor in ophthalmology in the department of ophthalmology and visual sciences at the University of Alabama at Birmingham, explains how hyperreflective foci — which are commonly detected during OCT B scans of patients with age-related macular degeneration — are “huge risk factors for the progression to atrophy.”

Using cone and rod mediated vision, Curcio and her lab worked with clinicians to determine if there were “functional correlates to the presence of HRF,” and the findings were presented at this year’s virtual ARVO annual meeting.

“We should believe the B scans, they will help us win AMD,” Curcio said.

Reference

  • Curcio CA, et al. Hyperreflective foci and specks are associated with delayed rod-mediated dark adaptation in non-neovascular age-related macular degeneration (AMD). Presented at: Association for Research in Vision and Ophthalmology annual meeting; June 12, 2020 (virtual meeting).